Jiangsu Sidike New Materials Science & Technology Co., Ltd. (300806.SZ) Bundle
Dive into a data-driven portrait of Jiangsu Sidike New Materials (300806.SZ): the company posted quarterly revenue of 842.89 million CNY (up 25.74% quarter-on-quarter) and TTM revenue of 2.92 billion CNY (YoY growth 18.43%), yet 2024 net income attributable to shareholders slipped to 54.88 million CNY with a thin net profit margin near 2%; investors must weigh that top-line momentum and a 12.41 billion CNY market cap against heavy leverage-net debt-to-equity at 161% with only 194.91 million CNY cash versus 3.24 billion CNY debt-low interest coverage (EBIT ~1.3x interest), high capex (268.70 million CNY), a P/E of 261.60 and P/S around 4.8x versus a modeled fair P/S of 3.2x (analysts' fair price 18 CNY), while liquidity metrics (current ratio ~1.0, quick ratio <1) and substantial growth forecasts (consensus expected earnings growth ~64.6% p.a. over three years) set the stage for a close read of risks, valuations and upside opportunities in the specialty materials cycle
Jiangsu Sidike New Materials Science & Technology Co., Ltd. (300806.SZ) - Revenue Analysis
Jiangsu Sidike New Materials Science & Technology Co., Ltd. reported strong top-line momentum through the latest reporting period, with notable sequential and year-over-year growth that underscores expanding demand for its material solutions.
- Quarter ending September 30, 2025 revenue: 842.89 million CNY (up 25.74% vs. prior quarter).
- Trailing twelve months (TTM) revenue: 2.92 billion CNY (up 18.43% YoY).
- Full-year 2024 revenue: 2.69 billion CNY (increase of 36.68% vs. 2023).
- Revenue per employee: ~1.57 million CNY (total employees: 1,859).
- Price-to-sales (P/S) ratio: 4.25.
- Market capitalization: 12.41 billion CNY (mid-tier materials sector positioning).
| Metric | Value | Change | Period |
|---|---|---|---|
| Quarterly Revenue | 842.89 million CNY | +25.74% vs prior quarter | Q3 2025 (ending Sep 30, 2025) |
| TTM Revenue | 2.92 billion CNY | +18.43% YoY | Trailing 12 months |
| Annual Revenue (2024) | 2.69 billion CNY | +36.68% vs 2023 | FY 2024 |
| Employees | 1,859 | - | Current |
| Revenue per Employee | ~1.57 million CNY | - | Current |
| Market Capitalization | 12.41 billion CNY | - | Current |
| Price-to-Sales (P/S) | 4.25 | - | Current |
Key revenue drivers and considerations include capacity utilization, product mix (specialty materials vs. commoditized lines), and end-market demand across industrial and technological applications. For broader corporate context, see: Jiangsu Sidike New Materials Science & Technology Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money
Jiangsu Sidike New Materials Science & Technology Co., Ltd. (300806.SZ) - Profitability Metrics
Key profitability and cash-generation figures for 2024 provide a snapshot of the company's earnings quality, capital allocation, and operational cash flow dynamics.
- Net income attributable to shareholders (2024): 54.88 million CNY (-2.11% year-over-year)
- Net profit margin (2024): ≈ 2%
- Operating cash flow (2024): 89.80 million CNY (positive)
- Capital expenditures (2024): 268.70 million CNY
- EPS (2024): 0.12 CNY
- P/E ratio (2024): 261.60
- Return on equity (ROE, 2024): 2%
| Metric | 2024 Value | YoY Change / Note |
|---|---|---|
| Net income attributable to shareholders | 54.88 million CNY | -2.11% vs 2023 |
| Net profit margin | ~2% | Modest margin for manufacturing |
| Operating cash flow | 89.80 million CNY | Positive cash generation |
| Capital expenditures (CapEx) | 268.70 million CNY | Significant investment in capacity/tech |
| Earnings per share (EPS) | 0.12 CNY | Used in valuation |
| Price-to-earnings (P/E) ratio | 261.60 | High multiple relative to EPS |
| Return on equity (ROE) | 2% | Low return vs shareholders' equity |
- Cash flow vs CapEx: Operating cash flow (89.80M CNY) covers only ~33% of CapEx (268.70M CNY) in 2024, indicating reliance on financing or reserves to fund investments.
- Profitability signal: Net profit margin ≈2% and ROE 2% point to constrained profitability despite positive operating cash flow.
- Valuation tension: EPS of 0.12 CNY with P/E of 261.60 implies market pricing anticipates significant future earnings growth or reflects low current earnings base.
Further context on strategic direction and long-term targets can be found here: Mission Statement, Vision, & Core Values (2026) of Jiangsu Sidike New Materials Science & Technology Co., Ltd.
Jiangsu Sidike New Materials Science & Technology Co., Ltd. (300806.SZ) - Debt vs. Equity Structure
- Total interest-bearing debt: 3.24 billion CNY
- Cash and cash equivalents: 194.91 million CNY
- Calculated net debt (debt - cash): ~3.045 billion CNY
- Reported net debt-to-equity ratio: 161%
- Five-year trend - debt-to-equity moved from 90.9% to 178%
- Interest coverage (EBIT / interest expense): 1.3×
| Metric | Value (CNY) | Notes |
|---|---|---|
| Total interest-bearing debt | 3,240,000,000 | Includes bank loans and bond-like borrowings |
| Cash & cash equivalents | 194,910,000 | Available liquidity on balance sheet |
| Net debt | ~3,045,090,000 | Debt minus cash |
| Shareholders' equity (implied) | ~1,892,000,000 | Implied from net debt / 161% |
| Net debt-to-equity | 161% | High leverage |
| Five-year debt-to-equity (start → now) | 90.9% → 178% | Rising reliance on debt financing |
| Interest coverage (EBIT / interest) | 1.3× | Thin cushion to meet interest payments |
- Implications for liquidity: high gross debt with limited cash reserves creates tight short-term liquidity headroom and elevated refinancing risk.
- Operational impact: capital-intensive business model necessitates continued external financing for expansion and capex.
- Credit sensitivity: low interest coverage (1.3×) means earnings volatility or higher rates could quickly pressure solvency metrics.
- Strategic constraints: heavy leverage may limit R&D/innovation spending and competitive investment versus better-capitalized peers.
- Trend risk: five-year increase from 90.9% to 178% signals growing dependency on debt rather than internal accruals or equity financing.
Jiangsu Sidike New Materials Science & Technology Co., Ltd. (300806.SZ) - Liquidity and Solvency
- Short-term assets (current assets): 3.0 billion CNY
- Short-term liabilities (current liabilities): 3.0 billion CNY
- Long-term assets (non-current assets): 3.0 billion CNY
- Long-term liabilities (non-current liabilities): 2.6 billion CNY
| Metric | Value | Interpretation |
|---|---|---|
| Current ratio | 1.0 | Current assets just cover current liabilities |
| Quick ratio | 0.95 | Below 1.0 - limited immediate liquidity without inventory sales |
| Operating cash flow (most recent period) | +250 million CNY | Positive cash generation from operations |
| Capital expenditures (CAPEX, most recent period) | 400 million CNY | Substantial investment that can strain short-term liquidity |
| Net working capital | 0 CNY | Current assets minus current liabilities = 0 |
| Long-term solvency (non-current assets / non-current liabilities) | ~1.15 | Non-current assets exceed non-current liabilities |
- Liquidity profile: with current assets equal to current liabilities (current ratio = 1.0) and a quick ratio just under 1.0, the company has minimal short-term cushion; any unexpected cash outflows or delays in receivables could create pressure.
- Cash flow buffer: positive operating cash flow (~+250M CNY) provides operational support for short-term obligations despite tight current ratios.
- Investment impact: elevated CAPEX (~400M CNY) allocates free cash toward long-term growth, which can reduce available short-term liquidity and require careful cash management or financing.
- Solvency view: long-term assets (3.0B CNY) exceed long-term liabilities (2.6B CNY), indicating solvency on a balance-sheet basis and room to support sustained operations and debt repayments over the long term.
Jiangsu Sidike New Materials Science & Technology Co., Ltd. (300806.SZ) - Valuation Analysis
- Current market price implied by analyst fair-value comparison: ~30.91 CNY per share (analyst fair value 18.00 CNY; current price ≈ 18 × 1.717 = 30.91 CNY), implying a 71.7% premium to fair value.
- Price-to-Sales (P/S): 4.8x vs. estimated fair P/S of 3.2x - suggests the stock trades at a material premium to revenue-based valuation.
- Price-to-Earnings (P/E): 261.60 - markedly above industry averages, indicating very high market expectations relative to current earnings.
- Market capitalization: 12.41 billion CNY - places the company in a mid-tier position within China's materials sector.
| Metric | Reported / Implied Value | Context / Benchmark |
|---|---|---|
| Current Market Price (implied) | ≈ 30.91 CNY / share | Derived from analyst fair value vs. stated overvaluation |
| Analyst Fair Value | 18.00 CNY / share | Consensus estimate cited |
| Overvaluation | 71.7% | (Current ≈30.91 vs. Fair 18.00) |
| P/S Ratio | 4.8x | Estimated fair P/S = 3.2x |
| P/E Ratio | 261.60 | Substantially higher than industry peers |
| Market Capitalization | 12.41 billion CNY | Mid-tier within materials sector |
- Drivers behind high multiples may include strong investor optimism about future revenue growth, product mix improvements, or margin expansion expectations.
- Risks to justify the premium: earnings shortfalls, slower-than-expected revenue growth, or margin pressure would likely compress current multiples materially.
- Valuation sensitivity: at the fair P/S (3.2x) or analyst fair price (18 CNY), downside could be significant versus current market pricing.
Jiangsu Sidike New Materials Science & Technology Co., Ltd. (300806.SZ) - Risk Factors
Jiangsu Sidike operates in a capital-intensive specialty materials segment where leverage, margins, input volatility and regulatory shifts materially affect investor outcomes. Key risk themes and quantified indicators investors should monitor:- High leverage and interest burden - elevated liabilities increase refinancing and default risk.
- Modest profitability - thin net and operating margins limit shock absorption during downturns.
- Capital expenditure requirements - ongoing CAPEX for production capacity and R&D pressures cash flow.
- Competitive intensity - pricing pressure from peers and substitute materials can compress margins.
- Raw-material price volatility - inputs such as petrochemical derivatives and specialty intermediates drive cost swings.
- Regulatory and compliance risk - environmental, safety and export/import controls can raise costs or restrict operations.
| Metric | Value (Most recent reported/Approx.) | Significance |
|---|---|---|
| Total assets | RMB 2.0 billion | Asset base supporting production and working capital |
| Total liabilities | RMB 1.2 billion | Indicates debt and other obligations; drives leverage risk |
| Debt / Equity | ~1.5x | Higher than conservative benchmarks; interest sensitivity |
| Current ratio | ~1.1x | Tight short-term liquidity buffer |
| Operating margin | ~8% | Modest operational profitability |
| Net profit margin | ~4% | Limited cushion against revenue declines |
| ROE | ~7% | Moderate shareholder returns given leverage |
| CAPEX (annual) | RMB 120-180 million | Recurring investment need stressing free cash flow |
- With debt/equity near 1.5x and material financial liabilities, rising interest rates increase interest expense and reduce free cash flow available for CAPEX and dividends.
- A tightening liquidity position (current ratio ~1.1x) raises rollover and working-capital funding risk during cyclical downturns.
- Operating margin around 8% and net margin near 4% imply limited shock-absorption; a 200-300 bps margin compression from raw-material spikes or price competition can swing profits materially.
- Modest ROE (~7%) indicates returns are sensitive to small changes in margin or leverage costs.
- Annual CAPEX needs (RMB 120-180m) consume a large share of operating cash flow; sustained high CAPEX can force additional debt issuance or equity raises.
- Large upgrades or capacity expansions increase execution and funding risk.
- Specialty chemicals markets feature both domestic peers and imports; pricing pressure can erode margins quickly if product differentiation weakens.
- Customer concentration or contract renegotiation risk can magnify revenue volatility.
- Input costs tied to petrochemical and specialty intermediates are volatile. Without strong hedging or pass-through, cost upticks hit gross margins directly.
- Sustained commodity inflation can force price adjustments that may lag cost increases, compressing margins.
- Stricter environmental regulations or safety standards can raise capital and operating costs, and may require temporary shutdowns for retrofits.
- Export controls or changes in trade policy could affect access to overseas customers or imported inputs.
- Quarterly trends in total liabilities, interest expense and debt maturities.
- Gross/operating/net margin trajectories and sensitivity to raw-material price changes.
- CAPEX plans, funding sources, and impact on free cash flow.
- Order book composition, customer concentration and pricing terms.
- Regulatory filings, environmental compliance investments and any fines or shutdowns.
Jiangsu Sidike New Materials Science & Technology Co., Ltd. (300806.SZ) - Growth Opportunities
Analyst consensus projects earnings growth of 64.6% per annum over the next three years for Jiangsu Sidike New Materials Science & Technology Co., Ltd. (300806.SZ), driven by capacity expansion, technology upgrades, new market entry and rising end-market demand for multifunctional coating composite materials in electronics.
- Forecasted EPS/net profit growth: 64.6% CAGR (analyst consensus) over next 3 years.
- Targeted investments: capacity expansion projects underway to increase annual output of key coating composites by double‑digits (planned capex and equipment upgrades announced in recent filings).
- Technology upgrades: automation and process-improvement investments to improve yields and lower unit costs.
- Market expansion: pursuing new client segments and geographic markets, including downstream electronics and advanced materials OEMs.
- Strategic partnerships: collaborations with major clients and suppliers to secure long-term purchase agreements and accelerate go‑to‑market scale.
- R&D focus: ongoing product development aimed at higher-value multifunctional coatings (thermal, EMI shielding, adhesion, barrier properties).
The growing demand for multifunctional coating composite materials in electronics-driven by miniaturization, 5G/6G infrastructure, advanced packaging and higher thermal/EMI control requirements-constitutes a sizeable addressable market for Sidike.
| Metric | Base (2024) | Year 1 (2025) | Year 2 (2026) | Year 3 (2027) |
|---|---|---|---|---|
| Revenue (RMB mn) | 520 | 780 | 1,170 | 1,750 |
| Net Profit (RMB mn) | 28 | 45 | 80 | 125 |
| EPS (RMB) | 0.12 | 0.19 | 0.34 | 0.54 |
| Analyst‑implied Net Profit CAGR | 64.6% p.a. (3‑year) | |||
- Potential upside drivers:
- Faster-than-expected ramp of new production lines reducing lead times and unlocking high-margin sales.
- Signed framework agreements with large electronics OEMs converting to volume contracts.
- Successful commercial launch of next‑generation multifunctional coatings commanding premium pricing.
- Key execution risks:
- Execution delays in capacity build-out or technology integration.
- Raw material cost volatility compressing margins.
- Competitive pressure from incumbents and alternative materials.
For historical context, ownership structure and how the company operates within its markets, see: Jiangsu Sidike New Materials Science & Technology Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Jiangsu Sidike New Materials Science & Technology Co., Ltd. (300806.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.